AAAAAA

   
Results: 1-2 |
Results: 2
Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban
Authors: Kereiakes, DJ Lorenz, T Young, JJ Kukielka, G Mueller, MN Nanniazzi-Alaimo, L Phillips, DR
Citation: Dj. Kereiakes et al., Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban, J THROMB TH, 12(2), 2001, pp. 123-127
Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effectsof dalteparin or unfractionated heparin in combination with abciximab
Authors: Furman, MI Kereiakes, DJ Krueger, LA Mueller, MN Pieper, K Broderick, TM Schneider, JF Howard, WL Fox, ML Barnard, MR Frelinger, AL Michelson, AD
Citation: Mi. Furman et al., Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effectsof dalteparin or unfractionated heparin in combination with abciximab, AM HEART J, 142(5), 2001, pp. 790-798
Risultati: 1-2 |